Medtrade Shortlisted for the 2023 Great British Entrepreneur Awards
[Crewe, England, 15th June 2023 – Medtrade, a Cheshire-based Medical Device and Bio-Technology company, is excited to announce that they have been shortlisted for the prestigious 2023 Great British Entrepreneur Awards in two separate categories Scale-Up Entrepreneur of the Year and Technology Entrepreneur of the Year categories. This recognition reflects their exceptional entrepreneurial spirit, dedication, and remarkable achievements within their industry.
Now in its 11th year, and previously described as “The Grammys for Entrepreneurship”, The Great British Entrepreneur Awards celebrate the outstanding individuals and businesses that drive innovation, generate employment opportunities, and contribute to the growth of the UK economy. These awards serve as a platform to honour the remarkable stories of entrepreneurs who have overcome challenges, demonstrated resilience, and make significant contributions to their communities.
“We are delighted to be shortlisted for two Great British Entrepreneur awards. This underlines the amazing work our dedicated teams are doing on a daily basis here at Medtrade, and we are all extremely grateful for this recognition” said Russ Mably, CEO, at Medtrade.
The Great British Entrepreneur Awards have become one of the most coveted accolades for entrepreneurs across the UK, celebrating the nation’s diverse entrepreneurial landscape. The awards ceremony will take place on November 20th 2023 at London’s Grosvenor House, where industry leaders, innovators, and influencers will gather to celebrate the achievements of the finalists.
Founder of The Great British Entrepreneur Awards Francesca James says “Every year I am blown away with the quantity and quality of applications we receive, and this year is no exception. The Great British Entrepreneur Awards receives thousands of applications annually and the competition is tough. I am truly inspired by the remarkable accomplishments of this year’s finalists. Their collective achievements of generating over £2.7 billion in turnover and employing over 33,000 people demonstrate the exceptional impact they have made in their industries and communities. These entrepreneurs exemplify the spirit of innovation, resilience, and growth that drives the entrepreneurial landscape in the UK.”
Medtrade have been shortlisted in two separate categories given their broad contribution and significant contribution to medical innovation throughout the year. Firstly, the Scale-Up Entrepreneur of the Year recognises the incredible contribution the team have made towards supporting the Ukraine war in providing over 1 million lifesaving CELOX haemostatic bandages to the front line and helping to save many hundreds of lives during the conflict. Medtrade increase manufacturing output 7 fold within 3 weeks of the conflict starting and managed to deliver the first shipment to the front line in just 3 days.
The second award for Technology Entrepreneur of the Year recognises the companies use of the lifesaving CELOX haemostatic technology where the team have redesigned the product for the management of severe bleeding following childbirth, better known as Postpartum Haemorrhage (PPH). Today over 80,000 mothers die of PPH globally and PPH remains the leading cause of maternal mortality around the world. Medtrade are committed to making CELOX PPH available at every delivery across the world. In recent studies CELOX PPH has demonstrated over 95% success rate in bleeding control and a 78% reduction in hysterectomy rates vs. the current standard of care and has recently been granted CE (MDR) approval allowing Medtrade to commercialise globally. Given its unique mode of action and product make up, CELOX PPH is well placed to be adopted in both a high and low resourced setting.
Medtrade has excelled in the development and scale up of a lifesaving technology and has continued to innovate the CELOX technology to address some of the most traumatic medial situations. Their commitment to saving lives every day with a dedicated team of highly skilled people whose passion is to continue innovating and address unmet clinical needs across the world has allowed them to make a significant impact in the Health Care market and set new benchmarks for success.
The team at Medtrade is proud to have reached this stage and is grateful for the support received from their customers, partners, and the community. The recognition of their hard work by the Great British Entrepreneur Awards further motivates them to continue their journey of success and inspire others in the entrepreneurial ecosystem.
For more information about the Great British Entrepreneur Awards, please visit www.greatbritishentrepreneurawards.com. To learn more about Medtrade please visit www.medtrade.co.uk
About the Great British Entrepreneur Awards:
The Great British Entrepreneur Awards, now in its 11th year, celebrates the achievements of the UK’s most innovative and forward-thinking entrepreneurs. These awards highlight the exceptional contributions entrepreneurs make to the economy and society as a whole. For more information, please visit www.greatbritishentrepreneurawards.com
Established in 1999, Medtrade is a UK-based biotechnology company developing and launching industry-leading solutions to partners across the world. With offices in Crewe, UK and New York, US, the highly experienced leadership and specialist teams are committed to supporting business partners and healthcare practitioners with market-leading solutions across women’s health, wound care, trauma and haemostasis sectors. Medtrade manages the entire product development process through to full product commercialisation. Integral to the success of Medtrade is the continued focus on innovation and a dedicated team is in place. New innovations aimed at addressing key global healthcare challenges such as biofilms, wound treatment, infection prevention, pressure injury prevention and control of bleeding are very much the focus.